Keith L Knutson

This inventor holds 10 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, University of Washington. Active years: 2009-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith L Knutson. Retrieved from https://idiyas.com/inventor/keith-l-knutson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 8)

% Patents Active = 80.0

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 34(Granted Patents)

Location History:

Rochester, MN (US) (2009 - 2017)
Fort Pierce, FL (US) (2017)
Ft. Pierce, FL (US) (2018)
Jacksonville, FL (US) (2018 - 2021)

Company Filing History:

9 out of 1,810

Mayo Foundation for Medical Education and Research

patents

2 out of 2,173

University of Washington

patents

where one patent can have more than one assignee

Years Active: 2009-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10948480 - Immunity to folate receptors (2021-03-16),

2. 10556943 - HLA-DR binding peptides and their uses (2020-02-11),

3. 10117919 - [object Object] (2018-11-06),

4. 9915646 - Immunity to folate receptors (2018-03-13),

5. 9814767 - Methods and materials for generating CD8+ T cells having the ability to recognize cancer cells expressing a HER2/neu polypeptide (2017-11-14),

6. 9678071 - Detecting latent tuberculosis infections (2017-06-13),

7. 9243033 - Immunity to folate receptors (2016-01-26),

8. 8858952 - Methods and materials for generating T cells (2014-10-14),

9. 8486412 - Immunity to folate receptors (2013-07-16),

10. 7622128 - [object Object] (2009-11-24),

Title: Keith L Knutson: Innovator in Cancer Immunology

Introduction

Keith L Knutson is a prominent inventor based in Rochester, MN (US), known for his significant contributions to the field of cancer immunology. With a total of 10 patents, he has developed innovative methods and materials that enhance our understanding of immune responses related to cancer.

Latest Patents

Among his latest patents, one notable invention is related to "Immunity to Folate Receptors." This document provides methods and materials for assessing immunity to folate receptors, including techniques for evaluating FRα immunity in mammals. Additionally, it outlines methods for stimulating immunity to these receptors. Another significant patent is focused on "HLA-DR Binding Peptides and Their Uses." This invention presents HLA-DR (MHC class II) binding peptides derived from ovarian and breast cancer-associated antigens, such as Human Epidermal Growth Factor Receptor 2 (HER-2/neu), Carcinoembryonic Antigen (CEA), Insulin Growth Factor Binding Protein 2 (IGFBP-2), and Cyclin D1. These immunogenic peptides have potential applications in cancer vaccines.

Career Highlights

Throughout his career, Keith has worked with esteemed organizations, including the Mayo Foundation for Medical Education and Research and the University of Washington. His work has significantly advanced the field of cancer research and immunotherapy.

Collaborations

Keith has collaborated with notable colleagues, including Lynn C Hartmann and Kimberly R Kalli, contributing to various research projects and innovations in cancer treatment.

Conclusion

Keith L Knutson's innovative work in cancer immunology has led to the development of valuable patents that enhance our understanding of immune responses and potential treatments for cancer. His contributions continue to impact the field significantly.

Profile summary based on public USPTO records.